News Health

BioAraba signs an agreement with Chicago University

2013 March 11

BioAraba, the Health Research Institute, has signed an agreement with the Comer Children Hospital at Chicago University (USA) to conduct studies into sleep disorders in children.

The collaboration will focus on conducting studies into sleep apneas and from the perspective of genetics, in order to establish the natural history of the disease and its potential harmful consequence for the health of the patient if left undiagnosed and untreated.

Doctor David Gozal, director of the US centre and the leading expert in this field worldwide, has concluded in his research studies that children with untreated sleep apnea lose between 10 and 20 intellectual coefficient points in their adult life. This condition may lead to failure at school and health problems, particularly, the neuro-cognitive and cardiovascular ones.

As is known, the Sleep Disorder Interdisciplinary Unit, run by Dr. Carlos Egea, has been diagnosing and treating sleep disorders in children, with over 5,000 seen during that a 17-year period. Pulmonologists, paediatricians, neurophysiologists, psychologists, biologists and social workers are involved in the Unit. The Txagorritxu Sleep Unit, as it is popularly known, is a benchmark in Spain and carries out important research work.

The signed agreement is going to allow research into the genetic aspects that are behind childhood sleep apneas and the natural history of the disease. The great population mobility in the United States prevents long-term monitoring of the patients (which is something essential for success in any study). The mobility level in Álava is very small, which means that those children can be monitored for years and the natural history of the diseases studied overall.

BioAraba presentation at HUA Santiago

On the other hand, on 7 March, BioAraba was presented to the HUA Santiago professionals, as part of some seminars that will also be held in Txagorritxu.
As is known, BioAraba brings together all the public research conducted in Álava by the Osakidetza (Basque Health Service) workers and has agreements with institutions and companies to foster research projects likely to be transformed into innovation.

BioAraba currently has 280 researchers working on 134 projects. The financial resources obtained by those professionals in public calls exceed three million euros and the institute in Álava has been awarded 10% of the research funding in the Basque Country. This figure is expected to be doubled thanks to the entry of new partners in BioAraba (Eduardo Anitua Institute and others).

Comments are disabled for this document